Folgen
María J. Vicent
María J. Vicent
Prince Felipe Research Center
Bestätigte E-Mail-Adresse bei cipf.es - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Combination therapy: opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines
F Greco, MJ Vicent
Advanced drug delivery reviews 61 (13), 1203-1213, 2009
7142009
Polymer conjugates: nanosized medicines for treating cancer
MJ Vicent, R Duncan
Trends in biotechnology 24 (1), 39-47, 2006
5902006
Polymer therapeutics-prospects for 21st century: the end of the beginning
R Duncan, MJ Vicent
Advanced drug delivery reviews 65 (1), 60-70, 2013
4822013
Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics
M Barz, R Luxenhofer, R Zentel, MJ Vicent
Polymer Chemistry 2 (9), 1900-1918, 2011
4302011
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
R Duncan, MJ Vicent
Advanced drug delivery reviews 62 (2), 272-282, 2010
2812010
Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
R Duncan, MJ Vicent, F Greco, RI Nicholson
Endocrine-related cancer 12 (Supplement_1), S189-S199, 2005
2782005
Polymer therapeutics designed for a combination therapy of hormone‐dependent cancer
MJ Vicent, F Greco, RI Nicholson, A Paul, PC Griffiths, R Duncan
Angewandte Chemie 117 (26), 4129-4134, 2005
2632005
Polymer therapeutics: clinical applications and challenges for development
MJ Vicent, H Ringsdorf, R Duncan
Advanced drug delivery reviews 13 (61), 1117-1120, 2009
2372009
Polymer–drug conjugates as nano-sized medicines
F Canal, J Sanchis, MJ Vicent
Current opinion in biotechnology 22 (6), 894-900, 2011
1792011
Polymer-drug conjugates: current status and future trends
F Greco, MJ Vicent
Front Biosci 13 (7), 2744-2756, 2008
1442008
Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy
I Casanova-Salas, J Rubio-Briones, A Calatrava, C Mancarella, E Masiá, ...
The Journal of urology 192 (1), 252-259, 2014
1422014
Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel
A Eldar-Boock, K Miller, J Sanchis, R Lupu, MJ Vicent, R Satchi-Fainaro
Biomaterials 32 (15), 3862-3874, 2011
1422011
A controlled and versatile NCA polymerization method for the synthesis of polypeptides
I Conejos-Sánchez, A Duro-Castano, A Birke, M Barz, MJ Vicent
Polymer Chemistry 4 (11), 3182-3186, 2013
1282013
Current hurdles to the translation of nanomedicines from bench to the clinic
S Đorđević, MM Gonzalez, I Conejos-Sánchez, B Carreira, S Pozzi, ...
Drug delivery and translational research, 1-26, 2022
1272022
How important is the inert matrix of supported enantiomeric catalysts? Reversal of topicity with two polystyrene backbones
B Altava, MI Burguete, JM Fraile, JI García, SV Luis, JA Mayoral, ...
Angewandte Chemie 112 (8), 1563-1566, 2000
1232000
Peptide-based polymer therapeutics
A Duro-Castano, I Conejos-Sánchez, MJ Vicent
Polymers 6 (2), 515-551, 2014
1172014
Polymer–drug conjugates for novel molecular targets
J Sanchis, F Canal, R Lucas, MJ Vicent
Nanomedicine 5 (6), 915-935, 2010
1082010
Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer–Dox–AGM in breast cancer cells
F Greco, MJ Vicent, S Gee, AT Jones, J Gee, RI Nicholson, R Duncan
Journal of Controlled Release 117 (1), 28-39, 2007
1082007
Smart branched polymer drug conjugates as nano-sized drug delivery systems
A Duro-Castano, J Movellan, MJ Vicent
Biomaterials science 3 (10), 1321-1334, 2015
1032015
Relevance of folic acid/polymer ratio in targeted PEG–epirubicin conjugates
F Canal, MJ Vicent, G Pasut, O Schiavon
Journal of Controlled Release 146 (3), 388-399, 2010
972010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20